COCIR, the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry, published an open letter to the European Commission & National Competent Authorities for Medical Devices.
Half of clinical trials on the EU register have not reported results, despite rules requiring results to be posted within 12 months of completion, finds a study published by The BMJ. Findings show compliance has been poor overall, but companies show higher rates of compliance than academics
The U.S. Food and Drug Administration approved the first stand-alone prosthetic iris in the United States, a surgically implanted device to treat adults and children whose iris is completely missing or damaged due to a congenital condition called aniridia or other damage to the eye. The iris is made of thin, foldable medical-grade silicone and is custom-sized and colored for each individual…
Healthcare organisations across Europe are being warned to be ready for new laws which mark the biggest shake-up in data protection legislation in decades. The General Data Protection Regulation (GDPR) comes into effect across Europe on May 25, and despite the vote to leave the European Union the British Government has confirmed that it will be enshrined in UK law on that date. To help NHS and…
An Italian law requiring citizens to hold a certificate to use a defibrillator must change to improve survival from cardiac arrest, researchers argued today at Acute Cardiovascular Care 2018, a European Society of Cardiology congress. “Automated external defibrillator (AED) use before the arrival of the emergency medical services (EMS) plays a key role in improving victim survival from…
By 2020 medical devices manufacturers must document the clinical effectiveness of their devices more extensively. The Medical Device Regulation (MDR) presents a fundamental impact on innovation and price calculation for medical devices. Since the faulty PIP breast implants scandal in France (March 2010), there have been frequent calls for tighter licensing regulations for medical devices within…
Manufacturers are required to prevent so-called anomalous use. This includes, for instance, the use of cuvettes that are not licensed in products like Teco’s Coatron-X. Norms and directives are the backbone of medical devices manufacture. Frequent updates keep them current, but also often create unforeseen problems, especially for smaller and medium-size companies, because the bureaucracy is…
Radiographers are increasingly central to patient care, but the heterogeneous education and skills across Europe remain challenging. Dr Jonathan McNulty and Håkon Hjemly, of the European Federation of Radiographers Societies (EFRS), explained how they plan to improve radiographers’ visibility and work towards homogenising training across Europe, notably by launching a European Diploma in…
It is of grave concern that there has been no public consultation on government plans to enable accountable care organisations (ACOs) to operate in England, say experts in The BMJ. ACOs were conceived in the US in an effort to improve care and reduce growing health care costs. They involve government and private insurers awarding large contracts to commercial providers to run and provide…
Whilst Spain has announced a new record for organ donations the number in Germany is stabilising at a ‘low level’. The good news? The number did not fall any further following scandals surrounding the manipulation in the allocation of donor organs.
British NHS organisations are obliged by law to report people it fears at risk of becoming terrorists under the Prevent strategy - part of the UK government’s counterterrorism plan aimed at stopping people becoming terrorists. But new data collected by The BMJ has uncovered low levels of referrals to Prevent since the duty took hold, suggesting that it is having little impact in the NHS.
Dutch healthcare is internationally viewed as high level. However, the cost of care continues to rise, despite all the cuts.
Laboratory medicine delivery, regulation and accreditation vary between countries, e.g. Norway, Serbia and France recently aired at FiLM 2017. Leading figures explained the shape, scope and funding of healthcare and lab services and roles played by different professionals and challenges they face.
The Endocrine Society expressed disappointment in the European Commission's revised proposal on defining and identifying endocrine-disrupting chemicals (EDCs), citing unnecessarily narrow criteria for identifying EDCs that will make it nearly impossible for scientists to meet the unrealistically high burden of proof and protect the public from dangerous chemicals.
European regulators have turned the world of in vitro diagnostics (IVDs) upside down with new legislation that will come into effect at the end of this year. The new EU legislation gives manufacturers five years to meet strict standards. That may not be enough time.
New policy recommendations on preventing occupational exposure to cytotoxic drugs were launched in the European Parliament on 26 April 2016, an important new initiative designed to protect healthcare professionals working across the EU.
Bracco Imaging S.p.A., a global leading company in the diagnostic imaging business, today announced the approval of the use of MultiHance® (gadobenate dimeglumine) in Magnetic Resonance Imaging (MRI) of the whole body in adults and paediatric patients (> 2 years). The approval was obtained through a Mutual Recognition Procedure, with the Medicines and Healthcare products Regulatory Agency…
The U.S. Food and Drug Administration (FDA) has granted Siemens Healthcare Diagnostics Inc. (Siemens) an Emergency Use Authorization (EUA) for its real-time PCR Zika Virus assay, the VERSANT® Zika RNA 1.0 Assay (kPCR) Kit. With respect to Zika in vitro diagnostic tests, FDA has been authorized to issue EUAs to allow for use of unapproved medical products or unapproved uses of approved medical…
Patients and clinicians need greater regulatory transparency to make informed decisions about treatment Medical devices approved first in the European Union (EU) are associated with a greater rate of safety issues, finds a study published by The BMJ.
Around the world, especially in developing nations, counterfeit medicines are a real problem. Until now, in many countries there hasn't been a standard protocol to conduct investigations and pursue prosecution. New research, led by Michigan State University, is providing the foundation to apply criminology theory to preventing the production and sale of fake and substandard medicines.
COCIR welcomes the adoption of the European Data Protection Regulation (DPR). However, in order for the Regulation to deliver on its objectives, it is crucial that EU Member States move rapidly towards a harmonised interpretation and enforcement of its provisions. This will pave the way for growth, innovation and a data-driven healthcare sector.
Juries in criminal cases typically decide if someone is guilty, then a judge determines a suitable level of punishment. New research confirms that these two separate assessments of guilt and punishment – though related - are calculated in different parts of the brain. In fact, researchers found that they can disrupt and change one decision without affecting the other.
Noting a paradigm shift among consumers who are seeking greater control over their own healthcare, AACC issued a position statement today on direct-to-consumer laboratory testing, which allows people to order medical tests directly from a lab without having to work with their healthcare provider. The statement emphasizes direct-to-consumer test results must be accurate and easily understood—an…
The proposed EU draft IVD regulation looks set to have major implications for IVD manufacturers and laboratory-developed tests (LDTs). Replacing a current system that is inflexible, unresponsive and does not effectively protect patients, the new regulation will apply directly to all 28 EU countries and govern the manufacture and marketing of in vitro diagnostic devices (IVDs).
Leading infectious diseases experts have released new guidance for healthcare facilities looking to establish precautions for visitors of patients with infectious diseases. The guidance looks to reduce the potential for healthcare visitors in spreading dangerous bacteria within the healthcare facility and community. The recommendations are published online in Infection Control & Hospital…